Some refugees’ illness experiences preclude them from testifying and accurately representing their own interests during asylum adjudication proceedings.
AMA J Ethics. 2021;23(2):E132-139. doi:
10.1001/amajethics.2021.132.
By failing to follow informed consent protocols and regulations, a researcher engaging in CBPR may inflict permanent harm on the participating community and chill future research among disadvantaged populations.
Clinical trials for the blood substitute PolyHeme exposed the possibility for ambiguous interpretation of the FDA’s waiver of informed consent for emergency research.